Company: SXTPW
Filing Date: 2025-03-27
Form Type: S-1/A
Source: 0001013762-25-003353
Chunk: 198

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: S-1/A
Chunk 198
---
 executives and directors is c/o 1025 Connecticut Avenue NW Suite 1000, Washington,      
 D.C. 20036. On February 24, 2025, the Company effectuated a 1-for-5 Reverse Stock Split of its outstanding common stock. Accordingly, 
 all share numbers presented in this table have been adjusted to reflect the Reverse Stock Split.                                      |

| (2) | Includes                                                                                                                           
 (i) 4,471 shares of our common stock held in the name of Geoffrey Dow, (ii) 11,120 shares of common stock held by the Geoffrey S.  
 Dow Revocable Trust (the “Dow Trust”), of which Geoffrey Dow is the trustee and has control over the voting and disposition        
 of the shares of common stock held by the Dow Trust, (iii) 175 shares of common stock issuable upon exercise of warrants issued to 
 the Geoffrey S. Dow Revocable Trust and (iv) 1,000 shares underlying fully vested options exercisable into common stock at a per   
 share exercise price of $60.00.                                                                                                    |

| (3) | Includes                                                                                                                                
 (i) 5,274 shares of our common stock held in the name of Tyrone Miller, and (ii) 800 shares underlying fully vested options exercisable 
 into common stock at a per share exercise price of $60.00.                                                                              |

| (4) | Ms.                                                                                                                                 
 Landon beneficially owns a total of 5,374 shares of common stock, of which includes (i) 4,540 shares of common stock held in the    
 name of Ms. Landon, and (ii) 834 shares underlying fully vested options exercisable into common stock at a per share exercise price 
 of $6.85.                                                                                                                           |

| (5) | Mr.                                                                                                                              
 Allen beneficially owns a total of 518 shares of common stock, of which includes (i) 234 shares of common stock held in the name 
 of Mr. Allen, and (ii) 284 shares underlying fully vested options exercisable into common stock at a per share exercise price of 
 $318.00.                                                                                                                         |

| (6) | Ms.                                                                                                                                    
 Xu beneficially owns a total of 4,100 shares of common stock, of which includes (i) 3,816 shares of common stock held in the name      
 of Ms. Xu, and (ii) 284 shares underlying fully vested options exercisable into common stock at